Insights from Drosophila on mitochondrial complex I

Shauna-Kay Rhooms,Anjaneyulu Murari,Naga Sri Vidya Goparaju,Maximino Vilanueva,Edward Owusu-Ansah
DOI: https://doi.org/10.1007/s00018-019-03293-0
IF: 8
2019-09-04
Cellular and Molecular Life Sciences
Abstract:NADH:ubiquinone oxidoreductase, more commonly referred to as mitochondrial complex I (CI), is the largest discrete enzyme of the oxidative phosphorylation system (OXPHOS). It is localized to the mitochondrial inner membrane. CI oxidizes NADH generated from the tricarboxylic acid cycle to NAD<sup>+</sup>, in a series of redox reactions that culminates in the reduction of ubiquinone, and the transport of protons from the matrix across the inner membrane to the intermembrane space. The resulting proton-motive force is consumed by ATP synthase to generate ATP, or harnessed to transport ions, metabolites and proteins into the mitochondrion. CI is also a major source of reactive oxygen species. Accordingly, impaired CI function has been associated with a host of chronic metabolic and degenerative disorders such as diabetes, cardiomyopathy, Parkinson's disease (PD) and Leigh syndrome. Studies on <em class="EmphasisTypeItalic">Drosophila</em> have contributed to our understanding of the multiple roles of CI in bioenergetics and organismal physiology. Here, we explore and discuss some of the studies on <em class="EmphasisTypeItalic">Drosophila</em> that have informed our understanding of this complex and conclude with some of the open questions about CI that can be resolved by studies on <em class="EmphasisTypeItalic">Drosophila</em>.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?